Remove Clinical Trials Remove DEA Remove Epilepsy Remove Recreational
article thumbnail

New U.S. Research Efforts Could Catalyze Medical Cannabis’ Adoption in the Pharmaceutical Industry

Veriheal

Cannabis, despite being widely available for medical and recreational consumers across the United States, remains one of the most understudied plants. Drug Enforcement Agency (DEA). Additionally, numerous other cannabis-based medications have already gained approval or are in the process of being tested in clinical trials.

article thumbnail

CBD: Everything You Need to Know

CannaMD

Hemp is often used in manufacturing; whereas marijuana serves a primarily medicinal/recreational purpose. For example, the DEA considers Schedule I drugs to have a “high potential for abuse and the potential to create severe psychological and/or physical dependence.” One more difference? CBD Scheduling Rule Change. Glad you asked!

CBD 99
article thumbnail

Veriheal’s Innovation in Cannabis Scholarship 2020 Winners

Veriheal

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Supply chains are disrupted as a result, and consumers grow fearful of buying hemp.